about
Sequence variation divides Equine rhinitis B virus into three distinct phylogenetic groups that correlate with serotype and acid stabilityPrevalence of serum neutralising antibody to equine rhinitis A virus (ERAV), equine rhinitis B virus 1 (ERBV1) and ERBV2Detection of viruses in nasal swab samples from horses with acute, febrile, respiratory disease using virus isolation, polymerase chain reaction and serologyRecombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease.Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectinsFirst complete genome sequence of infectious laryngotracheitis virus.Attenuated vaccines can recombine to form virulent field viruses.Phylogenetic and molecular epidemiological studies reveal evidence of multiple past recombination events between infectious laryngotracheitis viruses.Growth kinetics and transmission potential of existing and emerging field strains of infectious laryngotracheitis virusProtection Induced in Broiler Chickens following Drinking-Water Delivery of Live Infectious Laryngotracheitis Vaccines against Subsequent Challenge with Recombinant Field Virus.The first genome sequence of a metatherian herpesvirus: Macropodid herpesvirus 1.Low genetic diversity among historical and contemporary clinical isolates of felid herpesvirus 1.Development and application of a TaqMan single nucleotide polymorphism genotyping assay to study infectious laryngotracheitis virus recombination in the natural host.Immune responses to infectious laryngotracheitis virus.Equine picornaviruses: well known but poorly understood.Equine gammaherpesviruses: perfect parasites?Update on viral diseases of the equine respiratory tract.Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice.Impairment of infectious laryngotracheitis virus replication by deletion of the UL[-1] gene.Evidence of widespread natural recombination among field isolates of equine herpesvirus 4 but not among field isolates of equine herpesvirus 1Marsupial and monotreme serum immunoglobulin binding by proteins A, G and L and anti-kangaroo antibody.Natural recombination in alphaherpesviruses: Insights into viral evolution through full genome sequencing and sequence analysis.Persistence and chronic urinary shedding of the aphthovirus equine rhinitis A virus.Identification of mixed equine rhinitis B virus infections leading to further insight on the relationship between genotype, serotype and acid stability phenotype.Horizontal transmission dynamics of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus.Glycoprotein G deletion mutants of equine herpesvirus 1 (EHV1; equine abortion virus) and EHV4 (equine rhinopneumonitis virus).Mapping B lymphocytes as major reservoirs of naturally occurring latent equine herpesvirus 5 infection.Spread of the newly emerging infectious laryngotracheitis viruses in Australia.Analysis of the complete genomic sequences of two virus subpopulations of the Australian infectious bronchitis virus vaccine VicS.Novel assay to quantify recombination in a calicivirus.Virological and serological investigation of Equid herpesvirus 1 infection in New Zealand.Genetic Diversity of Infectious Laryngotracheitis Virus during In Vivo Coinfection Parallels Viral Replication and Arises from Recombination Hot Spots within the Genome.Several recombinant capsid proteins of equine rhinitis a virus show potential as diagnostic antigens.Cross-protective immune responses between genotypically distinct lineages of infectious laryngotracheitis viruses.Comparing the genetic diversity of ORF30 of Australian isolates of 3 equid alphaherpesviruses.Seroprevalence study of Equine rhinitis B virus (ERBV) in Australian weanling horses using serotype-specific ERBV enzyme-linked immunosorbent assays.Comparative analysis of the complete genome sequences of two Australian origin live attenuated vaccines of infectious laryngotracheitis virus.Isolation and characterization of a novel herpesvirus from a free-ranging eastern grey kangaroo (Macropus giganteus).Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.Sialic acid acts as a receptor for equine rhinitis A virus binding and infection.
P50
Q28262869-7DD89A35-DE73-4416-8537-8D40CCF3C118Q28268789-9DAA6CA2-2780-4CBA-A00A-D584EF7C16BBQ28288153-D6B34015-9DC7-48CF-987B-8CEAFE3C7850Q33560566-1A98AFF3-3EBA-4076-B60E-DAD0DE046E23Q33629099-D31B04EB-5FA4-4925-B115-88308E939BE5Q33876002-12F8EFF3-0EE6-42B3-AA56-17DD8C857445Q34288335-AFA8947C-8239-47FB-B324-FC1096E8119FQ34577058-13A8221C-E07E-406F-A0C3-DD7978CB30FAQ35192770-207FFF75-7E6C-4192-922A-4024E1E5E161Q35772273-746A1EA3-1F20-4E9E-A435-3ADF3BBFBE00Q35901924-58F36701-0A38-4DCC-8C17-D5CEAF202861Q36121891-E14D9C47-71EF-4696-9A32-E8038164F81CQ36325388-61BA4262-A7D5-452C-8E98-84CA6C445232Q38097266-F853A677-A8CB-496A-9AC6-88297ADA4762Q38118808-A578F058-40DC-4CC4-ABC2-615329D388EEQ38120911-FA360148-BCC5-4C5F-9F4B-A7DC14A148D7Q38343000-AAD576B7-AAA8-4230-9D79-5DDB0677A2C6Q38349895-7A17D83E-3E95-4098-9C42-826D83A1104AQ38716586-7AE5CEA4-2674-4162-B8CA-1270276400E7Q38929399-1B5A87C6-7132-4288-9282-5A3693327E5FQ38947497-D134ED1C-0BFA-48E9-8801-2821DA1037AAQ39054773-E5C98A1F-E44D-4022-A82F-8761593760D7Q39238376-C9FD354E-28A6-4AD1-B9F5-E22F133B80F2Q39615662-D5F6C952-7244-4FE8-9E9F-2AB810EE0EFDQ39737403-3F04595E-6ECF-44E9-A078-359A0B6142B8Q40391771-DB7AA7EE-CF2D-4051-8CA4-96E4D1C71B17Q40429913-611CE228-DE58-48D7-B220-A104A26679A2Q40660330-D1F3D3F0-D49F-4CBB-8DE4-0925E7CC7546Q41344856-62461A62-2DA0-4450-886B-B45E912B5A4CQ41391582-3D4B46CE-EDA6-42B3-90BA-23DAADE67F69Q41457840-0B6B3AF2-A998-4931-9588-F8B6CAE34A93Q41931848-F835CC90-1B3E-4170-ADF8-0AD6A81BE7E5Q42052011-A3C10B04-C8D9-4C57-A668-0C12D8C777CCQ42218186-F13CB4C9-FF05-427C-A532-82D260F6E002Q42233218-C69016B9-40CC-460D-8512-B04FDC3DABAFQ42250584-AE576BD2-DD40-4656-BB99-5196C01177F9Q42623243-DEF8411A-0F43-47DA-A9BD-0B9C3DD21CA0Q44237086-596C0E38-58AB-4884-B8AA-82D94EDCC333Q44340655-2C283235-E898-4094-B6CE-7DFE6F9F7942Q45012708-5220A361-3C9C-49C4-A106-10D19C27CB50
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carol Hartley
@ast
Carol Hartley
@en
Carol Hartley
@es
Carol Hartley
@nl
Carol Hartley
@sl
type
label
Carol Hartley
@ast
Carol Hartley
@en
Carol Hartley
@es
Carol Hartley
@nl
Carol Hartley
@sl
prefLabel
Carol Hartley
@ast
Carol Hartley
@en
Carol Hartley
@es
Carol Hartley
@nl
Carol Hartley
@sl
P106
P1153
7103116393
P21
P31
P496
0000-0001-6174-7341